Cargando…
Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma
Molecularly targeted drugs are used in the treatment of a variety of malignant tumors, but this approach to developing novel therapies for oral squamous cell carcinoma (OSCC) has lagged behind the progress seen for other cancers. We have attempted to find appropriate molecular targets for OSCC and i...
Autores principales: | Tokuzen, Norihiko, Nakashiro, Koh-ichi, Tanaka, Hiroshi, Iwamoto, Kazuki, Hamakawa, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823039/ https://www.ncbi.nlm.nih.gov/pubmed/26497678 http://dx.doi.org/10.18632/oncotarget.6148 |
Ejemplares similares
-
Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma
por: Oka, Ryota, et al.
Publicado: (2015) -
MicroRNA‐361‐3p is a potent therapeutic target for oral squamous cell carcinoma
por: Ogawa, Himiko, et al.
Publicado: (2020) -
Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma
por: Tokuzen, Norihiko, et al.
Publicado: (2021) -
MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma
por: Nakashiro, Koh-ichi, et al.
Publicado: (2023) -
Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma
por: Fujita, Yohei, et al.
Publicado: (2014)